Hunt for Russian oligarch’s billions leads to biotech activist investor Alex Denner’s fund — report
The global dragnet being thrown out to capture billions of dollars in Russian oligarch money has spotlighted the role of an activist investor who’s spurred some of the most prominent reorganizations in biotech.
Following a story in the Wall Street Journal, the New York Times today flagged Alex Denner’s Sarissa Capital Management as one of a long list of funds that have worked with a low-profile firm called Concord Management. According to both newspapers, Concord has steered massive investments from Russian oligarch Roman Abramovich — worth an estimated $13 billion — to a variety of funds, including Sarissa, while keeping the oligarch’s name out of the transactions.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 144,300+ biopharma pros reading Endpoints daily — and it's free.